Literature DB >> 11827432

Mutation in hepatocyte nuclear factor-1alpha is not a common cause of MODY and early-onset type 2 diabetes in Korea.

H J Lee1, C W Ahn, S J Kim, Y D Song, S K Lim, K R Kim, H C Lee, K B Huh.   

Abstract

Maturity-onset diabetes of the young (MODY)-3 with a mutation in hepatocyte nuclear factor (HNF)-1alpha has been identified in most races, but the prevalence of Korean MODY and early-onset type 2 diabetes with a mutation in this gene is unknown. To determine the prevalence of MODY and early-onset type 2 diabetes with the mutation of HNF-1alpha gene in Korea, we analyzed this gene in 69 Korean early-onset type 2 diabetics and in 35 healthy persons using the single-strand conformation polymorphism (SSCP) technique and direct sequencing. We identified one mutation in exon 4 (C900A) in only one of the 69 Korean subjects with early-onset type 2 diabetes; this mutation was silent and did not change the amino acid (Pro300). Additionally, we identified four polymorphisms: S487N, AAC-->AGC, intron 2 (nt -23), intron 7: (nt +7) and intron 9 (nt -24). However, there was no significant difference in frequencies of the four polymorphisms between the type 2 diabetes and control groups. Among type 2 diabetics, codon 487 variant showed no relationship to age at onset, body mass index, fasting blood glucose, HbA1c, lipid profile, basal C-peptide and 2 hour C-peptide. We concluded that this genetic mutation in HNF-1alpha gene may not be a common contributor to MODY and early-onset type 2 diabetes susceptibility in Korea.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11827432     DOI: 10.1007/s005920170008

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  7 in total

Review 1.  Undiagnosed MODY: Time for Action.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

2.  Etiologic distribution and clinical characteristics of pediatric diabetes in 276 children and adolescents with diabetes at a single academic center.

Authors:  Ja Hye Kim; Yena Lee; Yunha Choi; Gu-Hwan Kim; Han-Wook Yoo; Jin-Ho Choi
Journal:  BMC Pediatr       Date:  2021-03-04       Impact factor: 2.125

3.  Cystatin C is not a good candidate biomarker for HNF1A-MODY.

Authors:  Natalia Nowak; Magdalena Szopa; Gaya Thanabalasingham; Tim J McDonald; Kevin Colclough; Jan Skupien; Timothy J James; Beata Kiec-Wilk; Elzbieta Kozek; Wojciech Mlynarski; Andrew T Hattersley; Katharine R Owen; Maciej T Malecki
Journal:  Acta Diabetol       Date:  2012-02-19       Impact factor: 4.280

4.  Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes Prevention.

Authors:  Liana K Billings; Kathleen A Jablonski; A Sofia Warner; Yu-Chien Cheng; Jarred B McAteer; Laura Tipton; Alan R Shuldiner; David A Ehrmann; Alisa K Manning; Dana Dabelea; Paul W Franks; Steven E Kahn; Toni I Pollin; William C Knowler; David Altshuler; Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

Review 5.  HNF1A:From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.

Authors:  Li-Mei Li; Bei-Ge Jiang; Liang-Liang Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

6.  Hepatocyte nuclear factor 1-alpha mutation in normal glucose-tolerant subjects and early-onset type 2 diabetic patients.

Authors:  Dong Mee Lim; Nam Huh; Keun Yong Park
Journal:  Korean J Intern Med       Date:  2008-12       Impact factor: 2.884

Review 7.  Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?

Authors:  Sung Hoon Kim
Journal:  Diabetes Metab J       Date:  2015-12       Impact factor: 5.376

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.